Blood Pressure Goals for Hypertension Guidelines: What Is Wrong With “Optimal”?

Journal of Clinical Hypertension

Volumn 8, Issue 12, 2006, Pages 835-839

  Giles, Thomas D ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CANDESARTAN; ENALAPRIL; INDAPAMIDE; PERINDOPRIL; PLACEBO; RAMIPRIL; ANTIHYPERTENSIVE AGENT;

ARTERIAL CIRCULATION; BLOOD PRESSURE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CORONARY ARTERY ATHEROSCLEROSIS; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; EDITORIAL; HEALTH CARE QUALITY; HEART OUTPUT; HUMAN; HYPERTENSION; MEDICAL TERMINOLOGY; OXYGEN CONSUMPTION; PRACTICE GUIDELINE; PREHYPERTENSION; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC BLOOD PRESSURE; PATHOPHYSIOLOGY; PATIENT CARE PLANNING; STANDARD;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION; PATIENT CARE PLANNING; PRACTICE GUIDELINES;

EID: 34848830266     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2006.06344.x     Document Type: Editorial

References (14)

1. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: a cooperative study. JAMA. 1977;237:255–261.
2. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1980;140:1280–1285.
3. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1984;144:1045–1057.
4. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988;148:1023–1038.
5. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154–183.
6. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, MD: National Institutes of Health; 1997. NIH Publication No. 98-4080.
7. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2571.
8. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med. 2004;164:2126–2134.
9. Moser M. From JNC I to JNC 7—what have we learned? Prog Cardiovasc Dis. 2006;48:303–315.
10. Giles TD, Berk BC, Black HR, et al., on behalf of the Hypertension Writing Group. Expanding the definition and classification of hypertension. J Clin Hypertens (Greenwich). 2005;7:505–512.
11. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145–153.
12. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–1041.
13. Julius S, Nesbitt SD, Eagan BM, et al., for the Trial of Preventing Hypertension (TROPHY) Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354:1685–1697.
14. Sipahi I, Tuzcu EM, Schoenhagen P, et al. Effects of normal, pre-hypertensive and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol. 2006;48:833–838.